These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32189594)

  • 1. Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.
    El-Sharawy S; Negm OE; Abd-Elsalam S; El-Sorogy HA; Shehata MAH
    Curr Cancer Drug Targets; 2020; 20(5):382-389. PubMed ID: 32189594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 3 genetic variants and susceptibility to hepatocellular carcinoma and HBV-related hepatocellular carcinoma.
    Li G; Zheng Z
    Tumour Biol; 2013 Jun; 34(3):1589-94. PubMed ID: 23404408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
    Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XRCC1 Gene Polymorphism Increases the Risk of Hepatocellular Carcinoma in Egyptian Population.
    Naguib M; Helwa MM; Soliman MM; Abdel-Samiee M; Eljaky AM; Hammam O; Zaghla H; Abdelsameea E
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):1031-1037. PubMed ID: 32334466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of XRCC1 p. Arg194Trp gene polymorphism with the risk of hepatocellular carcinoma in HCV Egyptian population: A pilot case-control study.
    Ghorab RA; Fouad SH; Elsaadawy Y; Hamdy M; Taha SI
    Int J Immunopathol Pharmacol; 2024; 38():3946320241265263. PubMed ID: 38898405
    [No Abstract]   [Full Text] [Related]  

  • 9. Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
    Saad H; Zahran MA; Hendy O; Abdel-Samiee M; Bedair HM; Abdelsameea E
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3725-3734. PubMed ID: 33369474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Inter-Relation between Leptin Receptor (Q223R) Gene Polymorphism and the Risk of Egyptian Patients with HCC.
    Karam HA; Bessa SS; Ali EMM; Diab T; Mohamed TM
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3557-3565. PubMed ID: 33369452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
    Ahmed HS; Wahab EA; Elhady HA; Elgerby MM
    Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.
    Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Alkahtani S; Alarifi S; Alkahtane AA; Al-Yahya H; Ali D; Alessia MS; Alshahrani B; Al-Ahdal MN; Al-Qahtani AA
    J Immunol Res; 2017; 2017():1590653. PubMed ID: 28127569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma.
    Labib HA; Ahmed HS; Shalaby SM; Wahab EA; Hamed EF
    Cell Immunol; 2015 Mar; 294(1):21-4. PubMed ID: 25666505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Polymorphism in Toll-Like Receptor 3 and Interferon Regulatory Factor 3 in Hepatitis C Virus-Infected Patients: Correlation with Liver Cirrhosis.
    Talaat RM; Elsayed SS; Abdel-Hakem NE; El-Shenawy SZ
    Viral Immunol; 2022 Nov; 35(9):609-615. PubMed ID: 36048530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV-related hepatocellular carcinoma in Egyptians.
    Motawi TMK; Sabry D; Shehata NI; William MM; Fahim AT
    J Biochem Mol Toxicol; 2022 Mar; 36(3):e22965. PubMed ID: 34783112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Methyltransferases as Potential Biomarkers for HCV Related Hepatocellular Carcinoma.
    Hassouna MM; Naguib M; Radwan EM; Abdel-Samiee M; Estaphan S; Abdelsameea E
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3357-3363. PubMed ID: 33247696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitinase 3-like-1, Tolloid-like protein 1, and intergenic gene polymorphisms are predictors for hepatocellular carcinoma development after hepatitis C virus eradication by direct-acting antivirals.
    Mangoud NOM; Ali SA; El Kassas M; Soror SH
    IUBMB Life; 2021 Feb; 73(2):474-482. PubMed ID: 33347699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.